Amy Shurtleff, , works in a biosafety level 4 laboratory at USAMRIID. Shurtleff is part of a team that evaluated the protective efficacy of Merck's EBOV vaccine, V920. (Image courtesy of USAMRIID)

---

Size: 1200px × 1800px
Photo credit: © AB Forces News Collection / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: &, -cb, .., africa, agency, agency’, army, biological, biology, cb, cbdp, chem/bio, chemical, combating, countering, cwmd, defen, defense, department, destruction, development, diseases, dtra, ebola, executive, infectious, institute, joint, jpeo, jpeo-cbd, jsto, mass, medical, merck, office, outbreak, program, reduction, research, science, synbio, synthetic, tech, technologies, technology, threat, usamriid, v920, weapons, west